Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Reversible cerebral vasoconstriction syndrome (RCVS) is an infrequent cerebrovascular disorder characterized by severe headaches with or without focal neurological deficits or seizures, and a reversible segmental and multifocal vasoconstriction of cerebral arteries.
Biomarker and diagnostic research for reversible cerebral vasoconstriction syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
2 clinical trials registered. Interventions under study include other interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
128 publications have been identified in PubMed for reversible cerebral vasoconstriction syndrome. Research spans Case Report / Case Series (55%), Review / Meta-Analysis (23%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 70 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 29 | 23% |
Disease patterns and progression | 16 | 13% |
Other research | 4 | 3% |
Testing and diagnosis research | 3 | 2% |
Clinical study results | 3 | 2% |
Laboratory research | 3 | 2% |
Salim HA (2026). [PMID: 42001768](https://pubmed.ncbi.nlm.nih.gov/42001768/). *Clin Neurol Neurosurg*. [Clinical Trial Publication]
de Sousa ÍA (2026). [PMID: 42053220](https://pubmed.ncbi.nlm.nih.gov/42053220/). *Headache*. [Review / Meta-Analysis]
Ramaswamy S (2026). [PMID: 41727342](https://pubmed.ncbi.nlm.nih.gov/41727342/). *Pregnancy (Hoboken)*. [Clinical Trial Publication]
Teixeira T (2026). [PMID: 41658708](https://pubmed.ncbi.nlm.nih.gov/41658708/). *Cureus*. [Case Report / Case Series]
Makkawi S (2026). [PMID: 42027389](https://pubmed.ncbi.nlm.nih.gov/42027389/). *Case Rep Neurol Med*. [Case Report / Case Series]
Nemes JN (2026). [PMID: 41715044](https://pubmed.ncbi.nlm.nih.gov/41715044/). *BMC Neurol*. [Case Report / Case Series]
Kawashima M (2026). [PMID: 42064473](https://pubmed.ncbi.nlm.nih.gov/42064473/). *Cureus*. [Case Report / Case Series]
Elangovan C (2026). [PMID: 40803833](https://pubmed.ncbi.nlm.nih.gov/40803833/). *Pract Neurol*. [Case Report / Case Series]
Otani K (2026). [PMID: 41769064](https://pubmed.ncbi.nlm.nih.gov/41769064/). *PCN Rep*. [Diagnostic / Biomarker]
Nagase T (2026). [PMID: 41005047](https://pubmed.ncbi.nlm.nih.gov/41005047/). *Int J Obstet Anesth*. [Case Report / Case Series]